1. Home
  2. RNP vs ARDX Comparison

RNP vs ARDX Comparison

Compare RNP & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers REIT and Preferred and Income Fund Inc.

RNP

Cohen & Steers REIT and Preferred and Income Fund Inc.

HOLD

Current Price

$18.42

Market Cap

984.5M

Sector

Finance

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$3.09

Market Cap

797.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNP
ARDX
Founded
2003
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
984.5M
797.8M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
RNP
ARDX
Price
$18.42
$3.09
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $12.90
AVG Volume (30 Days)
136.8K
★ 3.9M
Earning Date
01-01-0001
11-03-2026
Dividend Yield
★ 7.94%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,607,000.00
Revenue This Year
N/A
$19.98
Revenue Next Year
N/A
$27.70
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$18.01
$3.05
52 Week High
$21.88
$8.40

Technical Indicators

Market Signals
Indicator
RNP
ARDX
Relative Strength Index (RSI) 43.63 36.16
Support Level $18.01 N/A
Resistance Level $20.82 $3.35
Average True Range (ATR) 0.28 0.14
MACD 0.06 0.01
Stochastic Oscillator 65.36 14.19

Price Performance

Historical Comparison
RNP
ARDX

About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.

Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances. The Fund seeks to achieve its objectives through a portfolio of income producing common stock issued by REITs and preferred and other debt securities.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: